Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CytoDyn to Hold Webcast to Provide a Company Update By: CytoDyn Inc. via GlobeNewswire April 05, 2023 at 08:30 AM EDT VANCOUVER, Washington, April 05, 2023 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Hansen, our newly appointed Head of Research and Basic Science, will host an investment community webcast to provide a Company update on Tuesday, April 11, 2023. Following the update, questions submitted prior to the webcast as directed below will be addressed to the extent appropriate. Date: Tuesday, April 11, 2023Time: 1:00 pm PT / 4:00 pm ETAccess: https://event.choruscall.com/mediaframe/webcast.html?webcastid=1VcOPtAYQuestions: Please submit any questions prior to the webcast, and not later than Noon PT, Friday, April 7, 2023. Questions can be submitted via email to: ir@cytodyn.com. Per CytoDyn’s current policy, the presenters will not be able to take live questions during the webcast. This is a livestream presentation. Participants are encouraged to login early prior to the start of the event. The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until May 11, 2023. CONTACTSInvestors:Cristina De LeonOffice: 360.980.8524ir@cytodyn.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
CytoDyn to Hold Webcast to Provide a Company Update By: CytoDyn Inc. via GlobeNewswire April 05, 2023 at 08:30 AM EDT VANCOUVER, Washington, April 05, 2023 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Hansen, our newly appointed Head of Research and Basic Science, will host an investment community webcast to provide a Company update on Tuesday, April 11, 2023. Following the update, questions submitted prior to the webcast as directed below will be addressed to the extent appropriate. Date: Tuesday, April 11, 2023Time: 1:00 pm PT / 4:00 pm ETAccess: https://event.choruscall.com/mediaframe/webcast.html?webcastid=1VcOPtAYQuestions: Please submit any questions prior to the webcast, and not later than Noon PT, Friday, April 7, 2023. Questions can be submitted via email to: ir@cytodyn.com. Per CytoDyn’s current policy, the presenters will not be able to take live questions during the webcast. This is a livestream presentation. Participants are encouraged to login early prior to the start of the event. The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until May 11, 2023. CONTACTSInvestors:Cristina De LeonOffice: 360.980.8524ir@cytodyn.com
VANCOUVER, Washington, April 05, 2023 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Hansen, our newly appointed Head of Research and Basic Science, will host an investment community webcast to provide a Company update on Tuesday, April 11, 2023. Following the update, questions submitted prior to the webcast as directed below will be addressed to the extent appropriate. Date: Tuesday, April 11, 2023Time: 1:00 pm PT / 4:00 pm ETAccess: https://event.choruscall.com/mediaframe/webcast.html?webcastid=1VcOPtAYQuestions: Please submit any questions prior to the webcast, and not later than Noon PT, Friday, April 7, 2023. Questions can be submitted via email to: ir@cytodyn.com. Per CytoDyn’s current policy, the presenters will not be able to take live questions during the webcast. This is a livestream presentation. Participants are encouraged to login early prior to the start of the event. The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until May 11, 2023. CONTACTSInvestors:Cristina De LeonOffice: 360.980.8524ir@cytodyn.com